Updated : Jan 23, 2020 in Research Articles

New drug target for prostate cancer found in the non-coding genome

Scientists at Princess Margaret Cancer Centre have identified the drivers of a crucial gene involved in prostate cancer, revealing new targets for drug design.  Researchers…

Updated : Jan 16, 2020 in Expert Pitch

‘Are Noncommunicable Diseases Communicable?’ Rutgers Experts Available to Discuss Paper in Science Today

New Brunswick, N.J. (Jan. 16, 2020) – Rutgers professors Maria Gloria Dominguez-Bello and Martin J. Blaser are available to discuss a paper in the journal Science…

Updated : Jan 16, 2020 in Research Articles

Zika Virus’ Key into Brain Cells ID’d, Leveraged to Block Infection and Kill Cancer Cells

Zika virus infection can stunt neonatal brain development, a condition known as microcephaly, in which babies are born with abnormally small heads. To determine how…

Updated : Jan 16, 2020 in Research Articles

Partnership with China prompts change in care for high-risk type of leukemia

Researchers from St. Jude Children’s Research Hospital and the Chinese Children’s Cancer Group led the first randomized, Phase III clinical trial comparing targeted therapies for…

Updated : Jan 15, 2020 in Announcement

BLOOD STEM CELL RESEARCH

University of Delaware biomedical engineer Emily Day is working on technology that may one day replace bone marrow transplants.  Currently, bone marrow transplants are used…

Updated : Jan 14, 2020 in Research Articles

Unfruitful: Eating More Produce Will Not Cure, Stop Prostate Cancer

National guidelines recommend that men with prostate cancer eat a vegetable-rich diet, suggesting it might decrease cancer progression and death. But in a Phase III…

Updated : Jan 14, 2020 in Research Articles

Large Study of Subtle, Rare Genetic Differences Reveals Several New Clinically Relevant Targets for Variety of Diseases

Philadelphia, January 14, 2020 – While subtle differences in the number of genes copied from one individual and passed down to the next can be…

Updated : Jan 14, 2020 in Announcement

Douglas Hanahan Appointed Distinguished Scholar of the Ludwig Institute for Cancer Research

JANUARY 14, 2020, New York— Ludwig Cancer Research is pleased to announce the appointment of Douglas Hanahan as a Distinguished Scholar at the Lausanne Branch…

Updated : Jan 14, 2020 in Research Articles

Elevated Leukemia Incidence Is Found in World Trade Center Rescue and Recovery Workers

(New York, NY – January 14, 2020) – Responders who worked at the World Trade Center site after the attacks on September 11, 2001, have…

Updated : Jan 13, 2020 in Research Articles

How Marijuana Accelerates Growth of HPV-related Head and Neck Cancer Identified

University of California San Diego School of Medicine researchers have identified the molecular mechanism activated by the presence of tetrahydrocannabinol (THC) — the ingredient that…

Updated : Jan 13, 2020 in Research Articles

Investigational drugs block bone loss in mice receiving chemotherapy

Bone loss that can lead to osteoporosis and fractures is a major problem for cancer patients who receive chemotherapy and radiation. Since the hormone estrogen…

Updated : Jan 10, 2020 in Announcement

Sanft named Chief Patient Experience Officer at Smilow Cancer Hospital

New Haven, Conn. — Tara Sanft, M.D., associate professor of Medicine (Medical Oncology) and Director of the Smilow Cancer Hospital (SCH) Survivorship Clinic, has been…

Updated : Jan 09, 2020 in Research Articles

Study finds salt nanoparticles are toxic to cancer cells

A new study at the University of Georgia has found a way to attack cancer cells that is potentially less harmful to the patient. Sodium…

Updated : Jan 09, 2020 in Research Articles

Lack of insurance cause of survivorship gap in minorities with cancer, study shows

Lack of insurance coverage is a major cause of delayed breast cancer screening and treatment among minority women, which could lead to a decrease in…

Updated : Jan 08, 2020 in Research Articles

U-M Team Sheds New Light on the Role of Regulatory T Cells in Pancreatic Cancer

A multidisciplinary Michigan Medicine team is shedding new light on the role of regulatory T cells in pancreatic cancer — and, in mouse models, have…

Updated : Jan 06, 2020 in Research Articles

Can the flu shot help fight cancer?

Changing the microenvironment of tumors to increase the immune system’s response to them has been the goal of countless research and clinical studies including the…

Updated : Dec 29, 2019 in Research Articles

NUS and A*STAR scientists identify promising liver cancer-killing compounds with novel drug-screening platform

Scientists from the Cancer Science Institute of Singapore (CSI Singapore) at the National University of Singapore, and the Agency for Science, Technology and Research (A*STAR)’s…

Updated : Dec 27, 2019 in Research Articles

Proton therapy as effective as standard radiation with fewer side effects

Cancer patients who receive high-tech proton therapy experience similar cure rates and fewer serious side effects compared with those who undergo traditional X-ray radiation therapy,…

Updated : Dec 26, 2019 in Announcement

Yale Cancer Center launches Center for Community Engagement and Health Equity

New Haven, Conn. — Yale Cancer Center (YCC) announces the launch of the Center for Community Engagement and Health Equity (CEHE). Building on YCC’s longstanding…

Updated : Dec 26, 2019 in Research Articles

U-M Approach Could Improve the Accuracy of Cancer Clinical Trials

The approach, which was first implemented at U-M in 2016, could serve as a model for improving imaging assessments at other cancer centers where clinical…

Updated : Dec 23, 2019 in Research Articles

Researchers identify immune-suppressing target in glioblastoma

HOUSTON – Researchers at The University of Texas MD Anderson Cancer Center have identified a tenacious subset of immune macrophages that thwart treatment of glioblastoma…

Updated : Dec 20, 2019 in Research Articles

Finding Familiar Pathways in Kidney Cancer

(PHILADELPHIA) -- p53 is the most famous cancer gene, not least because it’s involved in causing over 50% of all cancers. When a cell loses…

Updated : Dec 16, 2019 in Announcement

Elizabeth Fox, M.D., named senior vice president of clinical trials research

St. Jude Children’s Research Hospital announced today that Elizabeth Fox, M.D., has been named senior vice president of clinical trials research. In this role, Fox…

Updated : Dec 12, 2019 in Feature Expert

Managing the Holidays with a Long-Term Illness

Advice from Oncology Social Workers Stringing the lights, storming the malls and all those parties! Imagine facing these holiday demands while you’re tired, sick, sad…

Updated : Dec 11, 2019 in Announcement

Jersey Shore University Medical Center Receives Re-Accreditation from the National Accreditation Program for Breast Centers

Hackensack Meridian Health Jersey Shore University Medical Center achieved re-accreditation from the National Accreditation Program for Breast Centers (NAPBC), a program administered by the American…

Updated : Dec 09, 2019 in Research Articles

New software tool uses AI to help doctors identify cancer cells

DALLAS – Dec. 9, 2019 – UT Southwestern researchers have developed a software tool that uses artificial intelligence to recognize cancer cells from digital pathology images…

Updated : Dec 09, 2019 in Research Articles

Yale Cancer Center study highlights challenges for care of AML patients during initial chemotherapy

Orlando, FL — A new study by Yale Cancer Center (YCC) researchers shows understanding treatment patterns for patients with acute myeloid leukemia (AML) is vital…

Updated : Dec 06, 2019 in Research Articles

Acupuncture reduces radiation-induced dry mouth for cancer patients

HOUSTON ― After receiving acupuncture treatment three days a week during the course of radiation treatment, head and neck cancer patients experienced less dry mouth,…

Updated : Dec 05, 2019 in Announcement

Guiding Lights: UC San Diego Launches Center for Fluorescence-Guided Surgery

In the 1990’s, Nobel Laureate Roger Tsien, PhD, took some of the first dramatic steps to revolutionize the field of surgery by introducing the concept…

Updated : Dec 05, 2019 in Research Articles

Taming chronic inflammation may reduce illness, save lives

Scientists from 22 institutions, including UCLA, are recommending early diagnosis, prevention and treatment of severe chronic inflammation to reduce the risk of chronic disease and…

Updated : Dec 03, 2019 in Research Articles

Roswell Park Team Identifies New Tumor Suppressor Protein in Prostate Cancer

Study is first to report that LRIG1 suppresses prostate cancer development LRIG1-derived peptide now being developed as anti-cancer therapeutic LRIG1 expression levels in tumors could…

Updated : Nov 27, 2019 in Research Articles

Researchers identify protein that governs human blood stem cell self-renewal

UCLA scientists have discovered a link between a protein and the ability of human blood stem cells to self-renew. In a study published today in…

Updated : Nov 27, 2019 in Feature

Zantac Recalled for Carcinogen Levels Above FDA Standards

The popular heartburn drug ranitidine, commonly known as Zantac, was voluntarily recalled due to the contamination of a human carcinogen that could potentially cause cancer.…

Updated : Nov 21, 2019 in Research Articles

Non-Coding DNA Located Outside Chromosomes May Help Drive Glioblastoma

One of the ways a cancer-causing gene works up enough power to turn a normal cell into a cancer cell is by copying itself over…

Updated : Nov 20, 2019 in Research Articles

Vicious Circles: Ring-shaped DNA Provides Cancer Cells with a Malignant Twist

Deoxyribonucleic acid or DNA encodes information, not only in its sequence but also in its shape. Building upon previous revelatory work, a team of scientists,…

Updated : Nov 20, 2019 in Feature

Two life threatening problems, one surgery

DALLAS – Nov. 20, 2019 – Juan Cueto did not feel sick, but he was losing weight rapidly and was devastated with the knowledge that…

Updated : Nov 19, 2019 in Announcement

Mayo Clinic, Hitachi to build first, next generation, carbon ion therapy treatment facility in North America

ROCHESTER, Minn. and TOKYO, Japan — Mayo Clinic and Hitachi, Ltd. have reached an agreement in principle to build a carbon ion treatment facility as part of…

Updated : Nov 19, 2019 in Research Articles

Anal cancer rates and mortality have risen dramatically among Americans

Rates of new anal cancer diagnoses and deaths related to human papillomavirus (HPV), the most common sexually transmitted infection, have increased dramatically over the last…

Updated : Nov 15, 2019 in Research Articles

Nudge Increases Cancer Screening Orders, But Patient-Facing Nudge Needed, Too

PHILADELPHIA – When the electronic health record is programmed to automatically flag and create orders for patients needing cancer screenings, doctors are significantly more likely…

Updated : Nov 14, 2019 in Announcement

Children’s National Hospital, Virginia Tech announce partnership for new Children’s National Research & Innovation Campus

Children’s National Hospital and Virginia Tech announce a formal partnership that will include the construction of a 12,000-square foot Virginia Tech biomedical research facility within…

Updated : Nov 13, 2019 in Announcement

LUDWIG LAUSANNE’S PING-CHIH HO NAMED AN EMBO YOUNG INVESTIGATOR

NOVEMBER 13, 2019, New York— Ludwig Cancer Research congratulates Ping-Chih Ho on his selection by the European Molecular Biology Association (EMBO) as a member of…

Updated : Nov 12, 2019 in Research Articles

Mount Sinai Researcher’s Examine the Metabolic Effects of an Oral Blood Cancer Drug

Contact: Kathryn Ullman                     Mount Sinai Press Office                     646-398-2065                     [email protected]   Mount Sinai Researcher’s Examine the Metabolic Effects of an Oral Blood Cancer…

Updated : Nov 08, 2019 in Research Articles

Approach to Personalizing Treatment of Triple-Negative Breast Cancer Shows Promise in Cell Lines

Triple-negative breast cancer is an aggressive cancer, one that’s likely to recur and to metastasize. It’s also quite diverse at the molecular level, and doctors…

Updated : Nov 06, 2019 in Announcement

MD Anderson, Artios Pharma and ShangPharma announce in-licensing agreement for DNA damage response inhibitor

HOUSTON, CAMBRIDGE, UK, NEW YORK and SOUTH SAN FRANSISCO -- The University of Texas MD Anderson Cancer Center, Artios Pharma Limited and ShangPharma Innovation today announce…

Updated : Nov 04, 2019 in Feature

Smilow Cancer Hospital expert explains five things you need to know about Lung Cancer

New Haven, Conn. — Lung cancer is the second most common cancer in both men and women in the United States. According to the American…

Updated : Nov 04, 2019 in Feature

Researchers investigate impact of actual and virtual nature on cancer patients

Researchers at Houston Methodist Cancer Center are exploring whether exposure to nature, through either a live garden or virtual reality, can alleviate pain and distress…

Updated : Nov 01, 2019 in Announcement

Nashville Predators to Honor Late CEO of Monroe Carell Jr. Children’s Hospital at Vanderbilt at Hockey Fights Cancer Game

When the Nashville Predators hockey team hits the ice Saturday, Nov. 2, the players will take on an important opponent: childhood cancer. The Hockey Fights…

Updated : Oct 31, 2019 in Research Articles

Study finds racial disparities in culturally competent cancer care

Non-white minority survivors are less likely than non-Hispanic whites to be seen by cancer specialists who share or understand their culture. The disparity is likely…

Updated : Oct 31, 2019 in Research Articles

LLNL leads multi-institutional team in modeling protein interactions tied to cancer

Computational scientists, biophysicists and statisticians from Lawrence Livermore National Laboratory (LLNL) and Los Alamos National Laboratory (LANL) are leading a massive multi-institutional collaboration that has…

Updated : Oct 28, 2019 in Research Articles

Treating the TOTAL patient: clinical trial reduces relapse

Despite modern therapies, 10% of patients with acute lymphoblastic leukemia (ALL) treated in the U.S. relapse, which dramatically reduces their chance of survival. Results from…